We postulate that tumor cells might utilize oncogenic potential to overcome Cdh1-deficiency caused genomic stress while taking advantage of the elevated Cdh1 downstream targets to facilitate their growth and metastasis. The gene discussed is CDH1; the disease is neoplasm.